Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Raffel

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Annals of Hematology|February 11, 2026
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trialLars Fransecky, Walter Fiedler, Christoph Röllig, et al.
Nature|June 1, 2017
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibitionGabriele Varano, Simon Raffel, Martina Sormani, et al.
Hemasphere|April 23, 2025
Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AMLKarin Huber, Swati Garg, Lena Schlautmann, et al.
Blood|June 20, 2020
Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cellsSimon Raffel, Daniel Klimmeck, Mattia Falcone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALLMatthias Stelljes, Simon Raffel, Nael Alakel, et al.
Aging|November 8, 2015
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibitionClemens Stockklausner, Simon Raffel, Julia Klermund, et al.
Nature Communications|March 2, 2021
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomicsLars Velten, Benjamin A Story, Pablo Hernández-Malmierca, et al.
Haematologica|February 13, 2023
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemiaNicola Gökbuget, Kristina Ihrig, Michael Stadler, et al.
Nature Immunology|November 23, 2021
Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell statesSergio Triana, Dominik Vonficht, Lea Jopp-Saile, et al.
Cancer Discovery|March 9, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/VenetoclaxAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Annals of Hematology|February 11, 2026
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trialLars Fransecky, Walter Fiedler, Christoph Röllig, et al.
Nature|June 1, 2017
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibitionGabriele Varano, Simon Raffel, Martina Sormani, et al.
Hemasphere|April 23, 2025
Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AMLKarin Huber, Swati Garg, Lena Schlautmann, et al.
Blood|June 20, 2020
Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cellsSimon Raffel, Daniel Klimmeck, Mattia Falcone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALLMatthias Stelljes, Simon Raffel, Nael Alakel, et al.
Aging|November 8, 2015
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibitionClemens Stockklausner, Simon Raffel, Julia Klermund, et al.
Nature Communications|March 2, 2021
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomicsLars Velten, Benjamin A Story, Pablo Hernández-Malmierca, et al.
Haematologica|February 13, 2023
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemiaNicola Gökbuget, Kristina Ihrig, Michael Stadler, et al.
Nature Immunology|November 23, 2021
Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell statesSergio Triana, Dominik Vonficht, Lea Jopp-Saile, et al.
Cancer Discovery|March 9, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/VenetoclaxAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Pageof 5